Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Experimental Hematology ; (6): 1455-1458, 2008.
Artigo em Chinês | WPRIM | ID: wpr-234213

RESUMO

The purpose of this study was to determine the changes of pathogens in hematological ward and susceptibility of patients received chemotherapy to antibiotics. The pathogens were taken from blood, urine and sputum of patients who accepted chemotherapy from years 2001 to 2005, then were isolated and identified. The susceptibility test was performed by disk diffusion method. The results showed that the total of 418 strains were detected. Gram-negative bacteria were the most common of nosocomial infection. Pseudomonas aeruginosa, Enterobacter cloacae, E. coli account for the most of Gram negative- bacteria infection and most resistant to broad-spectrum penicillin, Acinetobacter baumannii showed a trend of increase. The ratios of gram positive bacteria and fungi were increased slowly, mainly as Enterococcus and Candida. Enterococcus is the most common cause of Gram-positive bacterial infection. Vancomycin resistance did not occur. It is concluded that Gram-negative bacteria are main cause of nosocomial infection in patients with hematological malignancies. Gram positive bacteria and fungi had been more frequent. Strains resistant to antimicrobial agents increase.


Assuntos
Humanos , Infecção Hospitalar , Epidemiologia , Microbiologia , Farmacorresistência Bacteriana , Bactérias Gram-Negativas , Infecções por Bactérias Gram-Negativas , Epidemiologia , Microbiologia , Doenças Hematológicas , Microbiologia , Neoplasias Hematológicas , Microbiologia , Testes de Sensibilidade Microbiana
2.
Journal of Experimental Hematology ; (6): 1160-1162, 2006.
Artigo em Chinês | WPRIM | ID: wpr-282709

RESUMO

The purpose of this study was to construct the IgHV and IL-2 coexpressed vector. The IgHV gene fragments were obtained from the peripheral blood of patients with lymphoma, and were cloned into eukaryotic expression vector. Meanwhile, the gene fragments of IgHV linked with gene of IL-2 were inserted into pcDNA3.0 to form a fusion gene of IgHV-IL-2. Then fusion genes were transfected into COS cells by Lipofectin and the expression of IL-2 was detected by ELISA. The results showed that the IgHV/pcDNA3.0 expression vector was successfully constructed. The 3' end of IgHV was linked to IL-2 gene, and IL-2 could be correctly expressed. In conclusion, the expression vector of IgHV-IL-2 can express IL-2 correctly in COS cells.


Assuntos
Humanos , Vacinas Anticâncer , Alergia e Imunologia , Células Eucarióticas , Metabolismo , Genes de Imunoglobulinas , Vetores Genéticos , Cadeias Pesadas de Imunoglobulinas , Genética , Região Variável de Imunoglobulina , Genética , Interleucina-2 , Genética , Linfoma , Alergia e Imunologia , Proteínas Recombinantes de Fusão , Genética , Alergia e Imunologia , Vacinas de DNA , Genética , Alergia e Imunologia
3.
Journal of Experimental Hematology ; (6): 433-436, 2006.
Artigo em Chinês | WPRIM | ID: wpr-233574

RESUMO

This study was aimed to explore the expression of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 in bcr/abl fusion gene positive CML cells, and to study the effects of P210(bcr/abl) fusion protein tyrosine kinase on expression of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 mRNAs in chronic myeloid leukemia cells. The expression levels of MIP-1alpha, MCP-1 and their receptors CCR-1, CCR-2 mRNA were detected by semi-quantitative RT-PCR in bcr/abl negative cells, bcr/abl positive cells, and P210(bcr/abl)-Rb-C-Box positive cells. The results showed that MIP-1alpha and CCR-1 mRNAs were expressed in bcr/abl negative cells, but not in positive cells. Both MCP-1 and CCR-2 mRNA cannot be detected in both bcr/abl positive and negative cells. After inhibiting P210(bcr/abl) tyrosine kinase activity by Rb-C-Box, expressions of MIP-1alpha and CCR-1 mRNAs were restored to normal (similar to P210(bcr/abl) negative cells). It is concluded that P210(bcr/abl) fusion protein inhibits the expression of MIP-1alpha and CCR-1 in chronic myeloid leukemia cells, but does not inhibit MCP-1 and CCR-2 mRNA expressions in these leukemia cells.


Assuntos
Humanos , Quimiocina CCL2 , Genética , Quimiocina CCL3 , Quimiocina CCL4 , Leucemia Mielogênica Crônica BCR-ABL Positiva , Metabolismo , Proteínas Inflamatórias de Macrófagos , Genética , Receptores CCR1 , Receptores CCR2 , Receptores de Quimiocinas , Genética , Células Tumorais Cultivadas
4.
Chinese Journal of Hematology ; (12): 65-69, 2004.
Artigo em Chinês | WPRIM | ID: wpr-291474

RESUMO

<p><b>OBJECTIVE</b>To explore the feasibility of regulated expansion and committed differentiation potential of JAK2 gene modified hematopoietic stem/progenitor cells in vitro.</p><p><b>METHODS</b>A murine stem cell virus (MSCV) based retroviral vector MGI-F2Jak2, which encodes a green fluorescent protein (GFP) and a fusion protein containing two copies of modified FK506 binding protein (F36v) linked tyrosine kinase JAK2 was cloned. F36v served as a high-affinity binding site for dimerizer AP20187. GpE + 86 packaging cell was transfected with this vector. Bone marrow cells from C57BL/6 mice were transduced by co-cultured with irradiated (1500 cGy) GpE + 86 producer clone for 48 h. Transduced marrow cells were expanded in X-VIVO 15 and divided into four groups as follows: (1) control group; (2) AP20187 alone group; (3) SCF alone group and (4) AP20187 + SCF group. The phenotypes of the expanded cells were analyzed by directly phycoerythrin-labeled anti-Sca1, c-kit, CD(34), Gr1, CD(11b), TER119, CD(41), B220 and CD(3) monoclonal antibodies for flow cytometry. Committed differentiation, progenitor colony assay and spleen colony forming units (CFU-S) were further evaluated.</p><p><b>RESULTS</b>A significant sustained outgrowth of transduced marrow cells was obtained only in the AP20187 + SCF group. Cells expanded up to 10(14)-fold after 80 days culture. The doubling time was about 30 hs. The phenotypes of the expanded cells were homogeneously strong positive for CD(34), c-kit and Sca1, while were almost negative for Gr1, CD(11b), TER119, CD(41), B220 and CD(3). Functional assay demonstrated that the expanded cells had multipotential to differentiate into granulocyte, macrophage, erythrocyte, or B-cells under different cytokines combinations. A prominent megakaryocytic differentiation was observed when cultured with SCF/Tpo/IL-11 combination. The expanded cells were also capable of forming BFU-E, CFU-GM and CFU-Mix in methylcellulose colony assay. The expanded cells over three months could still form CFU-S.</p><p><b>CONCLUSIONS</b>AP20187 combined SCF mediated activation of JAK2 signaling domain can dramatically expand hematopoietic stem/progenitor cells, and the expanded cells can be regulated and committed to differentiate into multilineage cells. This system may provide important insights into stem cell biology and may be promising for gene and cell therapy.</p>


Assuntos
Animais , Feminino , Camundongos , Diferenciação Celular , Células-Tronco Hematopoéticas , Biologia Celular , Janus Quinase 2 , Camundongos Endogâmicos C57BL , Proteínas Tirosina Quinases , Genética , Fisiologia , Proteínas Proto-Oncogênicas , Tacrolimo , Farmacologia , Transfecção
5.
Chinese Journal of Hematology ; (12): 337-339, 2003.
Artigo em Chinês | WPRIM | ID: wpr-354867

RESUMO

<p><b>OBJECTIVES</b>To explore the effects of p210 bcr/abl fusion gene on expression of beta1 integrin and L-selectin mRNAs in mouse chronic myeloid leukemia (CML) cells.</p><p><b>METHODS</b>Comparisons of beta1 integrin and L-selectin mRNA levels among p210 bcr/abl negative, p210 bcr/abl positive, and p210 bcr/abl-Rb-C-Box positive cells were undertaken by quantity RT-PCR.</p><p><b>RESULTS</b>In p210 bcr/abl positive cells, L-selectin mRNA level was decreased, but beta1 integrin mRNA expression had no change as compared to those in p210 bcr/abl negative cells. When inhibition of bcr-abl tyrosine kinase activity by Rb-C-Box, the L-selectin mRNA expression restored to normal (similar to p210 bcr/abl negative cells).</p><p><b>CONCLUSION</b>p210 bcr/abl oncoprotein inhibits expression of L-selectin mRNA, but not of beta1 integrin mRNA.</p>


Assuntos
Animais , Camundongos , Linhagem Celular Tumoral , Proteínas de Fusão bcr-abl , Genética , Regulação Leucêmica da Expressão Gênica , Genes do Retinoblastoma , Genética , Integrina beta1 , Genética , Selectina L , Genética , Leucemia Mielogênica Crônica BCR-ABL Positiva , Genética , RNA Mensageiro , Genética , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA